{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:28:53Z","timestamp":1787923733135,"version":"build-2784847793"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.msard.2026.107344","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T16:49:00Z","timestamp":1782492540000},"page":"107344","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Pregnancy among women with neuromyelitis optica spectrum disorder: An updated case series from Iran"],"prefix":"10.1016","volume":"113","author":[{"given":"Masoud","family":"Etemadifar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Ghasemi Monjezi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Sanei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehri","family":"Salari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2796-6791","authenticated-orcid":false,"given":"Nahad","family":"Sedaghat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2026.107344_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102252","article-title":"Pre-pregnancy, obstetric and delivery status in women with neuromyelitis Optica spectrum disorder","volume":"44","author":"Ashtari","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107344_bib0002","unstructured":"Australian therapeutic goods administration rituximab ATG product label Available from: https:\/\/www.tga.gov.au\/sites\/default\/files\/auspar-rituximab-210412.pdf (Accessed on 15 Jan 2026)."},{"issue":"3","key":"10.1016\/j.msard.2026.107344_bib0003","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000339","article-title":"Female hormonal exposures and neuromyelitis Optica symptom onset in a multicenter study","volume":"4","author":"Bove","year":"2017","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"2","key":"10.1016\/j.msard.2026.107344_bib0004","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/mrcr\/rxab051","article-title":"Rituximab administration during the second trimester of pregnancy for systemic lupus erythematosus: case report and review of the literature on rheumatic disease","volume":"6","author":"Colquhoun","year":"2022","journal-title":"Mod. Rheumatol. Case Rep."},{"key":"10.1016\/j.msard.2026.107344_bib0006","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.544434","article-title":"Pregnancy and Neuromyelitis Optica spectrum disorder - reciprocal effects and practical recommendations: a systematic review","volume":"11","author":"D'Souza","year":"2020","journal-title":"Front. Neurol."},{"issue":"3","key":"10.1016\/j.msard.2026.107344_bib0005","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000453","article-title":"Rituximab before and during pregnancy: a systematic review, and a case series in MS and NMOSD","volume":"5","author":"Das","year":"2018","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"12","key":"10.1016\/j.msard.2026.107344_bib0007","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1002\/acn3.51683","article-title":"Effects of pregnancy on neuromyelitis Optica spectrum disorder and predictors of related attacks","volume":"9","author":"Du","year":"2022","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"14","key":"10.1016\/j.msard.2026.107344_bib0008","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1177\/1352458514537699","article-title":"An epidemiological study of neuromyelitis Optica in Isfahan","volume":"20","author":"Etemadifar","year":"2014","journal-title":"Multiple Sclerosis J."},{"key":"10.1016\/j.msard.2026.107344_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103127","article-title":"Conus medullaris involvement in demyelinating disorders of the CNS: a comparative study","volume":"54","author":"Etemadifar","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107344_bib0012","unstructured":"European Medicines Agency. Riximyo epar product information. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/riximyo-epar-product-information_en.pdf (Accessed on 15 Jan 2026)."},{"key":"10.1016\/j.msard.2026.107344_bib0011","unstructured":"European Medicines Agency. Ritemvia epar public assessment report. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/assessment-report\/ritemvia-epar-public-assessment-report_en.pdf (Accessed on 15 Jan 2026)."},{"key":"10.1016\/j.msard.2026.107344_bib0010","unstructured":"European Medicines Agency. Mabthera epar product information. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/mabthera-epar-product-information_en.pdf (Accessed on 15 Jan 2026)."},{"issue":"10","key":"10.1016\/j.msard.2026.107344_bib0013","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1007\/s00415-013-7031-y","article-title":"Neuromyelitis Optica and pregnancy","volume":"260","author":"Fragoso","year":"2013","journal-title":"J. Neurol."},{"issue":"3","key":"10.1016\/j.msard.2026.107344_bib0014","doi-asserted-by":"crossref","DOI":"10.1177\/20552173241271878","article-title":"Pregnancy characteristics in Egyptian female patients with NMOSD","volume":"10","author":"Gad","year":"2024","journal-title":"Multiple Sclerosis J. \u2013 Exper., Translational Clin."},{"issue":"15","key":"10.1016\/j.msard.2026.107344_bib0015","doi-asserted-by":"crossref","first-page":"7883","DOI":"10.3390\/ijerph18157883","article-title":"Translational research in cancer screening: long-term population-action bridges to diffuse adherence","volume":"18","author":"Hagoel","year":"2021","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"3","key":"10.1016\/j.msard.2026.107344_bib0016","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1177\/1753495X18813739","article-title":"Rituximab for the maintenance of minimal change nephropathy - a report of two pregnancies","volume":"13","author":"Holden","year":"2020","journal-title":"Obstet. Med."},{"key":"10.1016\/j.msard.2026.107344_bib0017","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3389\/fneur.2020.00501","article-title":"Epidemiology of neuromyelitis Optica spectrum disorder and its prevalence and incidence worldwide","volume":"11","author":"Hor","year":"2020","journal-title":"Front. Neurol."},{"issue":"6","key":"10.1016\/j.msard.2026.107344_bib0018","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/bpa.12084","article-title":"Aquaporin-4 antibodies (NMO-IgG) as a serological marker of neuromyelitis Optica: a critical review of the literature","volume":"23","author":"Jarius","year":"2013","journal-title":"Brain Pathol."},{"issue":"9","key":"10.1016\/j.msard.2026.107344_bib0019","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1177\/13524585251349125","article-title":"Four years on: pregnancy and birth outcomes reported in the MSBase pregnancy, neonatal outcomes, and Women's Health Registry (2020-2024)","volume":"31","author":"Jokubaitis","year":"2025","journal-title":"Mult. Scler."},{"issue":"16","key":"10.1016\/j.msard.2026.107344_bib0020","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1212\/WNL.0b013e318250d812","article-title":"Influence of pregnancy on neuromyelitis Optica spectrum disorder","volume":"78","author":"Kim","year":"2012","journal-title":"Neurology."},{"issue":"22","key":"10.1016\/j.msard.2026.107344_bib0021","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1212\/WNL.0000000000004681","article-title":"High risk of postpartum relapses in neuromyelitis Optica spectrum disorder","volume":"89","author":"Klawiter","year":"2017","journal-title":"Neurology."},{"issue":"3","key":"10.1016\/j.msard.2026.107344_bib0022","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s13311-022-01224-9","article-title":"Monoclonal antibodies in the treatment of relapsing multiple sclerosis: an overview with emphasis on pregnancy, vaccination, and risk management","volume":"19","author":"Krajnc","year":"2022","journal-title":"Neurotherapeutics"},{"issue":"641","key":"10.1016\/j.msard.2026.107344_bib0023","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abe9726","article-title":"In utero exposure to maternal anti-aquaporin-4 antibodies alters brain vasculature and neural dynamics in male mouse offspring","volume":"14","author":"Mader","year":"2022","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"10.1016\/j.msard.2026.107344_bib0024","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41582-020-0313-y","article-title":"Neuromyelitis Optica spectrum disorders and pregnancy: therapeutic considerations","volume":"16","author":"Mao-Draayer","year":"2020","journal-title":"Nat. Rev. Neurol."},{"issue":"11","key":"10.1016\/j.msard.2026.107344_bib0025","first-page":"683","article-title":"The prevalence of infertility in 20-49 years women in Yazd, 2014-2015: a cross-sectional study","volume":"16","author":"Mirzaei","year":"2018","journal-title":"Int. J. Reprod. Biomed."},{"issue":"3","key":"10.1016\/j.msard.2026.107344_bib0026","first-page":"183","article-title":"Epidemiological features of spontaneous abortion in the North Africa and the Middle East from 1990 to 2019: results from the Global burden of disease study 2019","volume":"16","author":"Moradinazar","year":"2022","journal-title":"J. Family. Reprod. Health"},{"issue":"1","key":"10.1016\/j.msard.2026.107344_bib0027","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1212\/WNL.0000000000002208","article-title":"Pregnancy outcomes in aquaporin-4-positive neuromyelitis Optica spectrum disorder","volume":"86","author":"Nour","year":"2016","journal-title":"Neurology."},{"issue":"12","key":"10.1016\/j.msard.2026.107344_bib0028","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1080\/10428194.2022.2100368","article-title":"Treatment of lymphoma with rituximab and chemotherapy during pregnancy","volume":"63","author":"On","year":"2022","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.msard.2026.107344_bib0029","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.3389\/fneur.2019.01070","article-title":"Pregnancy-related immune changes and demyelinating diseases of the Central nervous system","volume":"10","author":"Qiu","year":"2019","journal-title":"Front. Neurol."},{"issue":"11","key":"10.1016\/j.msard.2026.107344_bib0030","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1007\/s12031-020-01576-x","article-title":"Is fertility affected in women of childbearing age with multiple sclerosis or neuromyelitis Optica spectrum disorder?","volume":"70","author":"Sadeghpour","year":"2020","journal-title":"J. Mol. Neurosci."},{"issue":"Suppl 2","key":"10.1016\/j.msard.2026.107344_bib0031","first-page":"S491","article-title":"Pregnancy outcome in patients with neuromyelitis Optica spectrum disorder treated with rituximab: a case-series study","volume":"12","author":"Seyed Ahadi","year":"2021","journal-title":"Caspian. J. Intern. Med."},{"key":"10.1016\/j.msard.2026.107344_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2025.106568","article-title":"Family planning in neuromyelitis Optica spectrum disorder","volume":"101","author":"Shalaby","year":"2025","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"2","key":"10.1016\/j.msard.2026.107344_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103499","article-title":"Risks and outcomes of pregnancy in neuromyelitis Optica spectrum disorder: a comprehensive review","volume":"23","author":"Siriratnam","year":"2024","journal-title":"Autoimmun. Rev."},{"issue":"4","key":"10.1016\/j.msard.2026.107344_bib0034","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000734","article-title":"Rituximab, MS, and pregnancy","volume":"7","author":"Smith","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2026.107344_bib0035","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3389\/fneur.2018.00446","article-title":"Ovarian reserve in women with Neuromyelitis Optica spectrum disorder","volume":"9","author":"Th\u00f6ne","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.msard.2026.107344_bib0036","unstructured":"United States Food and Drug Administration. Rituximab FDA product label Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/103705s5367s5388lbl.pdf (Accessed on 15 Jan 2026)."},{"key":"10.1016\/j.msard.2026.107344_bib0037","unstructured":"United States Food and Drug Administration. Rituximab FDA product label 2 Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2010\/103705s5311lbl.pdf (Accessed on 15 Jan 2026)."},{"issue":"8","key":"10.1016\/j.msard.2026.107344_bib0038","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.25438","article-title":"Analysis of pregnancy-related attacks in neuromyelitis Optica spectrum disorder: a systematic review and meta-analysis","volume":"5","author":"Wang","year":"2022","journal-title":"JAMa Netw. Open"},{"issue":"2","key":"10.1016\/j.msard.2026.107344_bib0039","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis Optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology."},{"issue":"9","key":"10.1016\/j.msard.2026.107344_bib0040","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis Optica","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2026.107344_bib0041","unstructured":"World Health Organization. Infertility prevalence estimates, 1990\u20132021. Available from: https:\/\/www.who.int\/publications\/i\/item\/978920068315 (Accessed on 15 Jan 2026)."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826003809?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826003809?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T12:51:19Z","timestamp":1787921479000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034826003809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":41,"alternative-id":["S2211034826003809"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2026.107344","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pregnancy among women with neuromyelitis optica spectrum disorder: An updated case series from Iran","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2026.107344","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107344"}}